tiprankstipranks

Michael R. Hayden Insider Profile

18 Followers
Michael R. Hayden, Director at AbCellera Biologics, holds 1.49M shares in AbCellera Biologics (Ticker: ABCL), holds 78.30K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 0.00 shares in 89bio (Ticker: ETNB). Most recently, Michael R. Hayden Bought ― shares of AbCellera Biologics on Aug 24, 2026 for an estimated value of $570.44K.
tipranks
Michael R. Hayden

Michael R. Hayden
AbCellera Biologics (ABCL)
Director

Ranked #6,224 out of 108,921 Corporate Insiders

Profitable Transactions

53%
8 out of 15 Profitable Transactions

Average Return

+23.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$41M
47.17%
41.71%
11.13%
A breakdown of Michael R. Hayden's holdings

Insider Roles

Xenon
(XENE)
Director
AbCellera Biologics
(ABCL)
Director
Ionis Pharmaceuticals
(IONS)
Director
Roles that Michael R. Hayden holds in companies

Most Profitable Insider Trade

Stock:
Xenon
(XENE)
Rating:Informative Buy
Date:Aug 14, 2017 - Aug 14, 2018
Return:+356.00%
The most profitable trade made by Michael R. Hayden

Michael R. Hayden's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AbCellera Biologics
Aug 24, 2026
Director
Informative Buy
570.44K
$17.05M
Xenon
May 20, 2021
Director
Uninformative Buy
13.47K
$19.28M
Ionis Pharmaceuticals
Jul 31, 2026
Director
Informative Buy
1.06M
$4.55M
ETNB
89bio
Oct 30, 2025
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Michael R. Hayden's performance on stock

Michael R. Hayden insider profile FAQ

What is the percentage of profitable transactions made by Michael R. Hayden?
The percentage of profitable transactions made by Michael R. Hayden is 53%.
    What is the average return per transaction made by Michael R. Hayden?
    The average return per transaction made by Michael R. Hayden is 23.90%.
      What stocks does Michael R. Hayden hold?
      Michael R. Hayden holds: ABCL, XENE, IONS, ETNB stocks.
        What was Michael R. Hayden’s latest transaction?
        Michael R. Hayden latest transaction was an Informative Buy of $570.44K.
          What was Michael R. Hayden's most profitable transaction?
          Michael R. Hayden’s most profitable transaction was an Informative Buy of XENE stock on August 14, 2017. The return on the trade was 356.00%.
            What is Michael R. Hayden's role in AbCellera Biologics?
            Michael R. Hayden's role in AbCellera Biologics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.